These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6527814)

  • 21. [Evaluation of the methods of treating patients with malignant tumors].
    Pritsman IuIa; Shafir II; Chapliuk MI; Batinov IN; Stranadko EF
    Sov Med; 1986; (4):113-6. PubMed ID: 3715597
    [No Abstract]   [Full Text] [Related]  

  • 22. Breast cancer in young women.
    Diekamp U; Bitran J; Ferguson DJ
    J Reprod Med; 1976 Nov; 17(5):255-78. PubMed ID: 792443
    [No Abstract]   [Full Text] [Related]  

  • 23. T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy.
    Garg AK; Strom EA; McNeese MD; Buzdar AU; Hortobagyi GN; Kuerer HM; Perkins GH; Singletary SE; Hunt KK; Sahin A; Schechter N; Valero V; Tucker SL; Buchholz TA
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):138-45. PubMed ID: 15093909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Correlations between various anatomo-pathologic criteria of cancer of the breast and the determination of hormonal receptors].
    Lenzen B; Pletschette M; Capesius C
    Bull Soc Sci Med Grand Duche Luxemb; 1986; 123(2):79-81. PubMed ID: 3802373
    [No Abstract]   [Full Text] [Related]  

  • 25. Breast cancer. The treatment evolution.
    Knobf MK
    Am J Nurs; 1984 Sep; 84(9):1110-20. PubMed ID: 6566507
    [No Abstract]   [Full Text] [Related]  

  • 26. Induction chemotherapy and radiotherapy to avoid mastectomy in stage IIA-IIIA breast cancer.
    Hartmann KA; Waap I; Audretsch W; Muskalla K; Rezai M; von der Haar J; Schmitt G
    Oncol Rep; 1998; 5(2):503-6. PubMed ID: 9468589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Current modalities for breast cancer treatment].
    Sviatukhina OV
    Vestn Akad Med Nauk SSSR; 1980; (5):50-7. PubMed ID: 6994393
    [No Abstract]   [Full Text] [Related]  

  • 28. Breast cancer. Better treatments save more lives.
    Lewis C
    FDA Consum; 1999; 33(4):7-11. PubMed ID: 10443175
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hormonreceptors in the therapy concept of breast cancer (author's transl)].
    Jonat W; Maass H
    Arch Geschwulstforsch; 1981; 51(7):637-41. PubMed ID: 7337546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of breast cancer].
    Zornoza G; Clemente JL; de Oca J; Goena I; Fakih A
    Rev Med Univ Navarra; 1982 Mar; 26(1):15-22. PubMed ID: 7111947
    [No Abstract]   [Full Text] [Related]  

  • 31. Alternative therapy for elderly patients with breast cancer.
    von Rueden DG; Sessions SC
    Am Surg; 1994 Jan; 60(1):72-8. PubMed ID: 8273979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Negative margin status improves local control in conservatively managed breast cancer patients.
    Obedian E; Haffty BG
    Cancer J Sci Am; 2000; 6(1):28-33. PubMed ID: 10696736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decision making in surgery: management of symptomatic early breast carcinoma.
    Thomas P
    Br J Hosp Med; 1994 Mar 16-Apr 5; 51(6):287-9. PubMed ID: 8032564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiestrogen-cytotoxic chemotherapy and bacillus Calmette-Guerin vaccination in stage II breast cancer: seventy-two-month follow-up.
    Hubay CA; Gordon NH; Crowe JP; Guyton SP; Pearson OH; Marshall JS; Mansour EG; Hermann RE; Jones JC; Flynn WJ
    Surgery; 1984 Jul; 96(1):61-72. PubMed ID: 6740497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The prognostic value of cathepsin D concentration in cytosol of primary breast carcinoma].
    Bussen S; Rempen A; Caffier H
    Zentralbl Gynakol; 1995; 117(5):253-9. PubMed ID: 7793167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5-year follow-up after sentinel node mapping for breast cancer demonstrates better than expected treatment outcomes.
    Fuhrman GM; Gambino J; Bolton JS; Farr G; Jiang X
    Am Surg; 2005 Jul; 71(7):564-9; discussion 569-70. PubMed ID: 16089119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Infiltrating duct breast carcinoma: the role of estradiol and progesterone receptors].
    Salazar Esquivel EL; Morales Nájar R; Calzada Sánchez L
    Ginecol Obstet Mex; 1994 Mar; 62():85-90. PubMed ID: 8168725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improvement in the prognosis of Japanese breast cancer patients from 1946 to 2001--an institutional review.
    Yoshimoto M; Tada K; Hori H; Morota A; Tanabe M; Nishimura S; Takahashi K; Makita M; Iwase T; Kasumi F; Takahashi S; Ito Y; Oguchi M; Yamashita T; Akiyama F; Sakamoto G
    Jpn J Clin Oncol; 2004 Aug; 34(8):457-62. PubMed ID: 15371463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hormone replacement therapy and breast cancer risk.
    Gambrell RD
    Arch Fam Med; 1996 Jun; 5(6):341-8. PubMed ID: 8640324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Breast cancer: Needs in care and therapy].
    Kaulen H
    Dtsch Med Wochenschr; 2005 Oct; Suppl 1():72-3. PubMed ID: 16379248
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.